August 26, 2020 -- Qiagen announced the U.S. launch of a new digital SARS-CoV-2 detection test that can be done on a portable device. The device provides results in about 10 minutes, according to the company.
The Access anti-SARS-CoV-2 total test detects antibodies in people exposed to the novel virus. It will be available in the U.S. in the coming weeks after it receives an emergency use authorization from the U.S. Food and Drug Administration.
The test, which was developed in partnership with the Australian digital diagnostics company Ellume, has been shown to have both sensitivity and specificity of 100%.